A detailed history of Quarry LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Quarry LP holds 7,500 shares of TVTX stock, worth $126,450. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,500
Holding current value
$126,450
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.89 - $15.21 $59,175 - $114,075
7,500 New
7,500 $105 Million
Q1 2024

May 15, 2024

BUY
$7.18 - $9.82 $39,490 - $54,010
5,500 Added 122.22%
10,000 $77.1 Million
Q4 2023

Feb 14, 2024

SELL
$5.44 - $9.5 $29,920 - $52,250
-5,500 Reduced 55.0%
4,500 $40.5 Million
Q3 2023

Nov 14, 2023

BUY
$7.64 - $17.25 $76,400 - $172,500
10,000 New
10,000 $89.4 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.08B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.